HORA-RPE65 (Horama)

N/A

Report date: 2023/10/26 16:03:16

Base Information

Drug NameHORA-RPE65 (Horama)
Drug Alias NameHORA-RPE65
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionRPE65 gene transference
TargetsRetinoid isomerohydrolase
Therapy Area/IndicationsLeber Congenital Amaurosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesHorama Sa
China Registration ClassN/A

Develop Information

Active CompaniesHorama Sa
Inactive CompaniesN/A
Active IndicationsLeber Congenital Amaurosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A